Sichuan Biokin Stock Hits Day Low of CNY 201.02 Amid Price Pressure

Sichuan Biokin Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.63% to reach an intraday low of CNY 201.02. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.7% during the same period. Over the past week, Sichuan Biokin's stock has decreased by 4.02%, and its monthly performance reflects a significant drop of 23.02%. Year-to-date, the stock has faced a steep decline of 36.68%, while the China Shanghai Composite has remained relatively stable with a slight decrease of 0.24%. In the past year, Sichuan Biokin's stock has plummeted by 32.17%, contrasting sharply with the 16.95% gain of the broader index. The company's financial metrics indicate challenges, with net sales for the last nine months declining by 63.52% to CNY 2,065.9 million and a net profit loss of CNY 500.37 million, reflecting a 112.34% decrease. Additionally, the operating cash flow has reached a low of CNY -2,331.46 million. These figures highlight the current difficulties faced by Sichuan Biokin within the pharmaceuticals and biotechnology sector.